Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 88
Filter
1.
Acta Oncol ; 58(12): 1752-1756, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31512931

ABSTRACT

Background: Radiation therapy (RT) plays an important role in management of pediatric central nervous system (CNS) malignancies. Centers are increasingly utilizing pencil beam scanning proton therapy (PBS-PT). However, the risk of brainstem necrosis has not yet been reported. In this study, we evaluate the rate of brainstem necrosis in pediatric patients with CNS malignancies treated with PBS-PT.Material and methods: Pediatric patients with non-hematologic CNS malignancies treated with PBS-PT who received dose to the brainstem were included. All procedures were approved by the institutional review board. Brainstem necrosis was defined as symptomatic toxicity. The actuarial rate was analyzed by the Kaplan Meier method.Results: One hundred and sixty-six consecutive patients were reviewed. Median age was 10 years (range 0.5-21 years). Four patients (2.4%) had prior radiation. Median maximum brainstem dose in the treated course was 55.4 Gy[RBE] (range 0.15-61.4 Gy[RBE]). In patients with prior RT, cumulative median maximum brainstem dose was 98.0 Gy [RBE] (range 17.0-111.0 Gy [RBE]). Median follow up was 19.6 months (range, 2.0-63.0). One patient who had previously been treated with twice-daily radiation therapy and intrathecal (IT) methotrexate experienced brainstem necrosis. The actuarial incidence of brainstem necrosis was 0.7% at 24 months (95% CI 0.1-5.1%).Conclusion: The rate of symptomatic brainstem necrosis was extremely low after treatment with PBS-PT in this study. Further work to clarify clinical and dosimetric parameters associated with risk of brainstem necrosis after PBS-PT is needed.


Subject(s)
Brain Stem/radiation effects , Central Nervous System Neoplasms/radiotherapy , Proton Therapy/adverse effects , Adolescent , Astrocytoma/radiotherapy , Brain Stem/pathology , Child , Child, Preschool , Ependymoma/radiotherapy , Female , Humans , Infant , Kaplan-Meier Estimate , Male , Medulloblastoma/radiotherapy , Necrosis/epidemiology , Necrosis/etiology , Proton Therapy/methods , Radiation Dosage , Radiation Injuries/complications , Re-Irradiation/adverse effects , Young Adult
2.
J Evol Biol ; 28(4): 739-55, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25789690

ABSTRACT

Sexual selection drives fundamental evolutionary processes such as trait elaboration and speciation. Despite this importance, there are surprisingly few examples of genes unequivocally responsible for variation in sexually selected phenotypes. This lack of information inhibits our ability to predict phenotypic change due to universal behaviours, such as fighting over mates and mate choice. Here, we discuss reasons for this apparent gap and provide recommendations for how it can be overcome by adopting contemporary genomic methods, exploiting underutilized taxa that may be ideal for detecting the effects of sexual selection and adopting appropriate experimental paradigms. Identifying genes that determine variation in sexually selected traits has the potential to improve theoretical models and reveal whether the genetic changes underlying phenotypic novelty utilize common or unique molecular mechanisms. Such a genomic approach to sexual selection will help answer questions in the evolution of sexually selected phenotypes that were first asked by Darwin and can furthermore serve as a model for the application of genomics in all areas of evolutionary biology.


Subject(s)
Genomics/methods , Selection, Genetic , Sexual Behavior, Animal , Animals , Mating Preference, Animal
3.
J Evol Biol ; 22(1): 192-200, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19120819

ABSTRACT

Sexual reproduction is one of the most taxonomically conserved traits, yet sex-determining mechanisms (SDMs) are quite diverse. For instance, there are numerous forms of environmental sex determination (ESD), in which an organism's sex is determined not by genotype, but by environmental factors during development. Important questions remain regarding transitions between SDMs, in part because the organisms exhibiting unique mechanisms often make difficult study organisms. One potential solution is to utilize mutant strains in model organisms better suited to answering these questions. We have characterized two such strains of the model nematode Caenorhabditis elegans. These strains harbour temperature-sensitive mutations in key sex-determining genes. We show that they display a sex ratio reaction norm in response to rearing temperature similar to other organisms with ESD. Next, we show that these mutations also cause deleterious pleiotropic effects on overall fitness. Finally, we show that these mutations are fundamentally different at the genetic sequence level. These strains will be a useful complement to naturally occurring taxa with ESD in future research examining the molecular basis of and the selective forces driving evolutionary transitions between sex determination mechanisms.


Subject(s)
Biological Evolution , Caenorhabditis elegans/physiology , Sex Determination Processes , Temperature , Animals , Caenorhabditis elegans/genetics , Caenorhabditis elegans Proteins/genetics , Female , Linear Models , Male , Membrane Proteins/genetics , Mutation , Reproduction/physiology , Sex Ratio
4.
AJNR Am J Neuroradiol ; 28(4): 603-7, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17416804

ABSTRACT

As an essential part of the National Cancer Institute (NCI)-funded Pediatric Brain Tumor Consortium (PBTC), the Neuroimaging Center (NIC) is dedicated to infusing the study of pediatric brain tumors with imaging "best practice" by producing a correlative research plan that 1) resonates with novel therapeutic interventions being developed by the wider PBTC, 2) ensures that every PBTC protocol incorporates an imaging "end point" among its objectives, 3) promotes the widespread implementation of standardized technical protocols for neuroimaging, and 4) facilitates a quality assurance program that complies with the highest standards for image data transfer, diagnostic image quality, and data integrity. To accomplish these specific objectives, the NIC works with the various PBTC sites (10 in all, plus NCI/ National Institute of Neurological Diseases and Stroke representation) to ensure that the overarching mission of the consortium--to better understand tumor biology and develop new therapies for central nervous system tumors in children--is furthered by creating a uniform body of imaging techniques, technical protocols, and standards. Since the inception of the NIC in 2003, this broader mandate has been largely accomplished through a series of site visits and meetings aimed at assessing prevailing neuroimaging practices against NIC-recommended protocols, techniques, and strategies for achieving superior image quality and executing the secure transfer of data to the central PBTC. These ongoing evaluations periodically examine investigations into targeted drug therapies. In the future, the NIC will concentrate its efforts on improving image analysis for MR imaging and positron-emission tomography (PET) and on developing new ligands for PET; imaging markers for radiation therapy; and novel systemic, intrathecal, and intralesional therapeutic interventions.


Subject(s)
Brain Neoplasms/diagnosis , Magnetic Resonance Imaging , Multicenter Studies as Topic , Positron-Emission Tomography , Biomedical Research/organization & administration , Child , Humans , National Institutes of Health (U.S.) , United States
5.
AJNR Am J Neuroradiol ; 28(4): 666-71, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17416818

ABSTRACT

BACKGROUND AND PURPOSE: Optic nerve tortuosity is one of several nonmalignant abnormalities documented on MR imaging in patients with neurofibromatosis type 1 and may be related to the development of optic pathway gliomas. This study seeks an operational definition for optic nerve tortuosity. MATERIALS AND METHODS: A focus group of 3 pediatric neuroradiologists reviewed 20 MR images of the brain and orbits of patients suspected to have optic nerve tortuosity in the absence of optic pathway glioma and found 6 radiographic factors that occurred frequently. Subsequently, 28 MR images were assessed for the presence of optic nerve tortuosity, using a global assessment question that reflects a neuroradiologist's confidence in the presence of optic nerve tortuosity, and for the presence of the 6 radiographic factors, to identify a combination of these factors that best predicted a diagnosis of optic nerve tortuosity. RESULTS: We found perfect inter-rater agreement between 3 readers on the presence/absence of tortuosity in 75% of cases. Lack of congruity of the optic nerves, in more than 1 coronal section and dilation of the subarachnoid space surrounding the optic nerves, when found together are sensitive (89%) and specific (93%) for a diagnosis of tortuosity on the global scale. The absence of these 2 factors, along with absence of deviation of the optic nerve within the axial plane, provides a reliable test to exclude tortuosity. CONCLUSION: Lack of congruity of the optic nerves in more than 1 coronal section and dilation of the subarachnoid space surrounding the optic nerves together provide an operational radiographic definition of optic nerve tortuosity.


Subject(s)
Magnetic Resonance Imaging , Optic Nerve/abnormalities , Brain , Humans , Models, Statistical , Neurofibromatosis 1/complications , Neurofibromatosis 1/pathology , Observer Variation , Optic Nerve Glioma/complications , Optic Nerve Glioma/pathology , Orbit/pathology
6.
Eur J Cancer ; 43(10): 1581-9, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17446062

ABSTRACT

Central nervous system (CNS) atypical teratoid/rhabdoid tumours (AT/RT) are among the paediatric malignant tumours with the worst prognosis and fatal outcome. Insulin-like growth factor I receptor (IGF-IR) protects cancer cells from apoptosis induced by a variety of anticancer drugs and radiation. In the present study, IGF-IR was expressed in 8/8 primary AT/RT as detected by immunohistochemistry. Moreover, we found IGF-I and IGF-II mRNA in BT-16 CNS AT/RT cells and IGF-II mRNA in BT-12 CNS AT/RT cells, and autophosphorylated IGF-IR in both cell lines, indicating the potential presence of an autocrine/paracrine IGF-I/II/IGF-IR loop in CNS AT/RT. IGF-IR antisense oligonucleotide treatment of human CNS AT/RT cells resulted in significant down-regulation of IGF-IR mRNA and protein expression, induction of apoptosis, and chemosensitisation to doxorubicin and cisplatin. These studies provide evidence for the influence of IGF-IR on cellular responses to chemotherapy and raise the possibility that curability of selected CNS AT/RT may be improved by pharmaceutical strategies directed towards the IGF-IR.


Subject(s)
Apoptosis/drug effects , Central Nervous System Neoplasms/drug therapy , Oligoribonucleotides, Antisense/therapeutic use , Receptor, IGF Type 1/drug effects , Rhabdoid Tumor/drug therapy , Teratoma/drug therapy , Antineoplastic Agents/therapeutic use , Central Nervous System Neoplasms/pathology , Child , Child, Preschool , Cisplatin/therapeutic use , Down-Regulation , Doxorubicin/therapeutic use , Female , Humans , Infant , Insulin-Like Growth Factor I/metabolism , Male , Receptor, IGF Type 1/metabolism , Rhabdoid Tumor/pathology , Teratoma/pathology
7.
J Evol Biol ; 19(6): 1775-84, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17040374

ABSTRACT

Environmental sex determination has been documented in a variety of organisms for many decades and the adaptive significance of this unusual sex-determining mechanism has been clarified empirically in most cases. In contrast, temperature-dependent sex determination (TSD) in amniote vertebrates, first noted 40 years ago in a lizard, has defied a general satisfactory evolutionary explanation despite considerable research effort. After briefly reviewing relevant theory and prior empirical work, we draw attention to recent comparative analyses that illuminate the evolutionary history of TSD in amniote vertebrates and point to clear avenues for future research on this challenging topic. To that end, we then highlight the latest empirical findings in lizards and turtles, as well as promising experimental results from a model organism, that portend an exciting future of progress in finally elucidating the evolutionary cause(s) and significance of TSD.


Subject(s)
Biological Evolution , Reptiles/genetics , Sex Determination Processes , Adaptation, Biological , Animals , Caenorhabditis elegans/genetics , Ecology , Environment , Female , Male , Models, Biological , Phylogeny , Sex Ratio , Temperature
8.
Mol Ecol ; 12(5): 1325-37, 2003 May.
Article in English | MEDLINE | ID: mdl-12694294

ABSTRACT

Caenorhabditis elegans is a model organism in biology, yet despite the tremendous information generated from genetic, genomic and functional analyses, C. elegans has rarely been used to address questions in ecological genetics. Here, we analyse genetic variation for chemosensory behaviour, an ecologically important trait that is also genetically well characterized, at both the phenotypic and molecular levels within three species of the genus Caenorhabditis. We show that the G-protein ODR-3 plays an important role in chemosensory avoidance behaviour and identify orthologues of odr-3 in C. briggsae and C. remanei. Both quantitative genetic analysis of chemosensory behaviour and molecular population genetic analysis of odr-3 show that there is little genetic variation among a worldwide collection of isolates of the primarily selfing C. elegans, whereas there is substantially more variation within a single population of the outcrossing C. remanei. Although there are a large number of substitutions at silent sites within odr-3 among the three species, molecular evolution at the protein level is extremely conserved, suggesting that odr-3 plays an important role in cell signalling during chemosensation and/or neuronal cilia development in C. remanei and in C. briggsae as it does in C. elegans. Our results suggest that C. remanei may be a more suitable subject for ecological and evolutionary genetic studies than C. elegans.


Subject(s)
Behavior, Animal/physiology , Caenorhabditis elegans Proteins/genetics , Caenorhabditis elegans/genetics , Evolution, Molecular , GTP-Binding Protein alpha Subunits, Gi-Go/genetics , Genetic Variation , Animals , Base Sequence , Caenorhabditis elegans/physiology , Chromosome Mapping , Cluster Analysis , DNA Primers , Molecular Sequence Data , Phylogeny , Receptors, Odorant/genetics , Sequence Analysis, DNA , Signal Transduction/physiology
9.
Neurology ; 60(1): 130-2, 2003 Jan 14.
Article in English | MEDLINE | ID: mdl-12525736

ABSTRACT

An open-label phase I trial of thalidomide (TL) in 20 patients with neurofibromatosis 1 (NF1) treated symptomatic plexiform neurofibroma (PNF). TL was well tolerated in doses up to 200 mg/d. Adverse reactions included transient somnolence in four, evanescent rash in two, and reversible mild peripheral neuropathy in two patients. Four patients showed less than 25% reduction in the tumor size. TL may have a role in the treatment of PNF and should be explored in a larger controlled study, possibly using higher doses of TL.


Subject(s)
Head and Neck Neoplasms/drug therapy , Neoplasms, Multiple Primary/drug therapy , Neurofibroma, Plexiform/drug therapy , Neurofibromatosis 1/drug therapy , Pelvic Neoplasms/drug therapy , Spinal Neoplasms/drug therapy , Thalidomide/therapeutic use , Adolescent , Adult , Angiogenesis Inhibitors/adverse effects , Angiogenesis Inhibitors/therapeutic use , Child , Cohort Studies , Dermatologic Agents/adverse effects , Dermatologic Agents/therapeutic use , Dose-Response Relationship, Drug , Drug Eruptions/etiology , Female , Head and Neck Neoplasms/complications , Humans , Male , Neoplasms, Multiple Primary/complications , Neurofibroma, Plexiform/complications , Neurofibromatosis 1/complications , Pelvic Neoplasms/complications , Peripheral Nervous System Diseases/chemically induced , Sleep Stages/drug effects , Spinal Neoplasms/complications , Thalidomide/adverse effects , Treatment Outcome
10.
Eur J Cancer ; 38(1): 83-91, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11750844

ABSTRACT

Upon binding of tumour necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL), the agonistic TRAIL receptors DR4 and DR5 activate caspase-8 leading to apoptosis. In primitive neuroectodermal brain tumour (PNET) cell lines, TRAIL-induced apoptosis was recently shown to correlate with caspase-8 mRNA expression (Grotzer MA, Eggert A, Zuzak TJ, et al. Oncogene 2000, 19, 4604-4610). In this study, we analysed the expression of the TRAIL death pathway in 27 primary PNET/medulloblastoma. As shown by semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR), all PNET/medulloblastoma evaluated expressed DR5, the adapter protein FADD and caspase-3, but only 48% expressed caspase-8. The mRNA expression of caspase-8 was significantly lower in primary PNET/medulloblastoma compared with normal brain samples. PCR revealed >75% methylation of the caspase-8 promoter region in three of seven PNET cell lines and in 55% of the primary PNET/medulloblastoma evaluated. In the PNET cell lines, the methylation status correlated with the caspase-8 mRNA expression. We conclude that loss of caspase-8 gene expression is common in PNET/medulloblastoma suggesting that suppression of death receptor induced apoptosis may play an important role in the pathogenesis of this common childhood brain tumour.


Subject(s)
Adaptor Proteins, Signal Transducing , Brain Neoplasms/enzymology , Caspases/metabolism , Intracellular Signaling Peptides and Proteins , Neoplasm Proteins/metabolism , Neuroectodermal Tumors, Primitive/metabolism , Adolescent , Apoptosis Regulatory Proteins , CASP8 and FADD-Like Apoptosis Regulating Protein , Carrier Proteins/metabolism , Caspase 3 , Caspase 8 , Caspase 9 , Child , Child, Preschool , DNA Methylation , Fas-Associated Death Domain Protein , Female , Humans , Male , Medulloblastoma/enzymology , Membrane Glycoproteins/metabolism , RNA, Messenger/metabolism , RNA, Neoplasm , Receptors, TNF-Related Apoptosis-Inducing Ligand , Receptors, Tumor Necrosis Factor/metabolism , Reverse Transcriptase Polymerase Chain Reaction , TNF-Related Apoptosis-Inducing Ligand , Tumor Cells, Cultured , Tumor Necrosis Factor-alpha/metabolism
11.
Anticancer Res ; 21(4A): 2733-8, 2001.
Article in English | MEDLINE | ID: mdl-11724348

ABSTRACT

Mitogen-activated protein kinase and Phosphatidylinositol-3 kinase/Akt-mediated signaling pathways play a major role in controlling cell proliferation, differentiation and cell death. Phosphorylation and dephosphorylation of their specific Thr/Tyr residues is critical in determining their activity. We determined the expression pattern and activity of MAP kinases and Akt in Primitive Neuroectodermal Tumors (PNETs). The kinase activity of extracellular signal-regulated kinase (ERK) was higher in both primary tumors and cell lines, as evident from the increased phosphorylation of ERK1 and ERK2. We did not observe the activation of C-jun N-terminal kinase (JNK) or p38 MAPK The expression of Raf-1, a kinase acting upstream of ERK, was significantly increased in primary tumors compared to normal brain. The PI-3 kinase-activated phosphorylation of Akt was also higher in primary tumors. These results suggest that activation of the Raf-1/ERK module of the MAP kinase pathway play an important role in PNETs.


Subject(s)
Brain Neoplasms/enzymology , MAP Kinase Signaling System/physiology , Neuroectodermal Tumors, Primitive/enzymology , Protein Serine-Threonine Kinases , Humans , Mitogen-Activated Protein Kinases/biosynthesis , Mitogen-Activated Protein Kinases/metabolism , Proto-Oncogene Proteins/biosynthesis , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-akt , Proto-Oncogene Proteins c-raf/biosynthesis , Proto-Oncogene Proteins c-raf/metabolism , Tumor Cells, Cultured
12.
Eur J Cancer ; 37(16): 2064-72, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11597385

ABSTRACT

Primitive neuroectodermal brain tumours (PNET) including medulloblastomas (PNET/MB) are the most common malignant brain tumours of childhood. Similar to many other brain tumours, PNET/MB often show marked neovascularisation. To determine which angiogenic factors contribute to PNET/MB angiogenesis, we examined the expression of eight angiogenic factors (vascular endothelial growth factors (VEGF, VEGF-B, VEGF-C), basic fibroblast growth factor (bFGF), angiopoetins (Ang-1, Ang-2), transforming growth factor (TGF-alpha), and platelet-derived endothelial growth factor (PDGF-A)) by semi-quantitative reverse transcriptase polymerase chain reaction (RT-PCR) in six PNET cell lines and 28 primary PNET/MB. Expression levels of angiogenic factors were compared with microvessel density, TrkC mRNA expression, clinical variables and survival outcomes. Our results indicate that all PNET/MB tested produce a wide range of angiogenic factors that are, individually or together, likely to play a direct role in PNET/MB tumour growth. This suggests that anti-angiogenesis approaches targeting VEGF alone may be insufficient in PNET/MB.


Subject(s)
Angiogenesis Inducing Agents/metabolism , Brain Neoplasms/blood supply , Neovascularization, Pathologic/metabolism , Neuroectodermal Tumors, Primitive/blood supply , Adolescent , Angiogenesis Inducing Agents/genetics , Biomarkers, Tumor/genetics , Biomarkers, Tumor/metabolism , Brain Neoplasms/metabolism , Child , Child, Preschool , Follow-Up Studies , Gene Expression , Glioma/metabolism , Humans , Infant , Medulloblastoma/blood supply , Medulloblastoma/metabolism , Neovascularization, Pathologic/pathology , Neuroectodermal Tumors, Primitive/metabolism , RNA, Messenger/genetics , RNA, Neoplasm/genetics , Receptor, trkC/genetics , Receptor, trkC/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Survival Rate , Tumor Cells, Cultured
13.
Clin Cancer Res ; 7(8): 2425-33, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11489822

ABSTRACT

PURPOSE AND EXPERIMENTAL DESIGN: Cerebellar primitive neuroectodermal tumors/medulloblastomas (PNET/MB) are the most common malignant brain tumors in childhood. To identify PNET/MB biological prognostic factors that define a patient group with a sufficiently good prognosis to permit a reduction in treatment intensity, we determined the expression levels of MYC mRNA in fresh frozen tumor samples from 26 PNET/MB patients using semiquantitative reverse transcription-PCR. RESULTS: MYC mRNA expression levels in primary PNET/MB showed a wide range with a 22-fold difference between the highest and lowest values and did not correlate with MYC gene amplification. MYC mRNA expression was an independent significant prognostic factor for progression-free survival outcome and was more predictive than standard clinical factors. The combination of low MYC mRNA expression and high TrkC mRNA expression identified a good outcome group of PNET/MB patients (n = 7) with 100% progression-free survival after a median follow-up time of 55 months (range, 15-91 months). Three of these seven good outcome patients survived without radiotherapy. CONCLUSIONS: Low MYC mRNA expression is a powerful independent predictor of favorable clinical outcome in PNET/MB. Assessment of MYC mRNA levels is feasible and may be incorporated in prospective PNET/MB clinical trials to aid in treatment planning for patients with PNET/MB on confirmation of our results in larger studies.


Subject(s)
Cerebellar Neoplasms/pathology , Genes, myc/genetics , Neuroectodermal Tumors, Primitive/pathology , RNA, Messenger/metabolism , Cerebellar Neoplasms/genetics , Child , Child, Preschool , Female , Gene Expression Regulation, Neoplastic , Humans , Infant , Male , Medulloblastoma/genetics , Medulloblastoma/pathology , Neuroectodermal Tumors, Primitive/genetics , Predictive Value of Tests , Prognosis , RNA, Messenger/genetics , Receptor, trkC/genetics , Reverse Transcriptase Polymerase Chain Reaction , Survival Analysis , Tumor Cells, Cultured
14.
Genetics ; 158(3): 1137-45, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11454762

ABSTRACT

The pattern of genetic covariation among traits (the G matrix) plays a central role in determining the pattern of evolutionary change from both natural selection and random genetic drift. Here we measure the effect of genetic drift on the shape of the G matrix using a large data set on the inheritance of wing characteristics in Drosophila melanogaster. Fifty-two inbred lines with a total of 4680 parent-offspring families were generated by one generation of brother-sister mating and compared to an outbred control population of 1945 families. In keeping with the theoretical expectation for a correlated set of additively determined traits, the average G matrix of the inbred lines remained proportional to the outbred control G matrix with a proportionality constant approximately equal to (1 - F), where F is the inbreeding coefficient. Further, the pattern of covariance among the means of the inbred lines induced by inbreeding was also proportional to the within-line G matrix of the control population with a constant very close to the expectation of 2F. Although the average G of the inbred lines did not show change in overall structure relative to the outbred controls, separate analysis revealed a great deal of variation among inbred lines around this expectation, including changes in the sign of genetic correlations. Since any given line can be quite different from the outbred control, it is likely that in nature unreplicated drift will lead to changes in the G matrix. Thus, the shape of G is malleable under genetic drift, and the evolutionary response of any particular population is likely to depend on the specifics of its evolutionary history.


Subject(s)
Drosophila melanogaster/genetics , Animals , Female , Male , Phenotype
15.
Med Pediatr Oncol ; 36(2): 268-73, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11452934

ABSTRACT

BACKGROUND: Primitive neuroectodermal tumors (PNET) of the central nervous system, including medulloblastomas, are the most common malignant brain tumors of childhood. Whereas some patients experience prolonged disease control after surgery and adjuvant therapy, others with tumors that appear comparable will relapse and eventually die from progressive disease. PROCEDURE: Because proliferative activity may provide a potential correlate of biologic aggressiveness, PNETs of 78 well-characterized patients were evaluated by Ki-67 (MIB-1) immunohistochemistry. Proliferation indices (PI) were determined by counting Ki-67 (MIB-1) positive tumor cells either in the highest staining region (hot spot PI), or in at least 15 randomly chosen fields (random PI). RESULTS: Twenty-five of 78 PNETs showed amore than twofold higher value of hot spot PI (median 9.3%; range 0.6-56%), compared to random PI (median 5.6%; range 0.2-41.3%), Univariate Cox regression analysis revealed that PNETs with a high hot spot PI had a significantly greater risk of progression and death than PNETs with a low hot spot PI (hazard ratio 1.58, P = 0.04). The hazard ratio remained significant after adjusting for M-stage in multivariate analysis. In contrast to hot spot PI, random PI proved not to be a significant prognostic predictor. CONCLUSIONS: Hot spot PI is a significant and independent prognostic factor in PNETs. Its assessment is uncomplicated, reliable, and may supplement routine histologic examination as a means for improving the accuracy of predicting the biologic behavior of childhood PNETs.


Subject(s)
Brain Neoplasms/pathology , Ki-67 Antigen/analysis , Neuroectodermal Tumors, Primitive/pathology , Adolescent , Adult , Brain Neoplasms/mortality , Cell Division , Child , Child, Preschool , Humans , Immunohistochemistry , Infant , Neuroectodermal Tumors, Primitive/mortality , Prognosis
16.
Neuropediatrics ; 32(2): 75-9, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11414647

ABSTRACT

Microvessel density (MVD), a measure of tumor angiogenesis, has been shown to correlate significantly with overall and progression-free survival outcomes in various cancers including astrocytic brain tumors. To assess if the MVD is an independent prognostic factor in primitive neuroectodermal tumors (PNET) of the central nervous system, formalin-fixed paraffin-embedded tumor sections of 78 children with PNET were studied by CD34 immunohistochemistry to highlight endothelial cells. Microvessel density was determined in the most active area of neovascularization according to well-established methods. While it was shown that MVD showed considerable inter-tumor variability (median 75; range 20-345 microvessels per 0.7 mm2 field), no significant associations were found between MVD and metastasis or survival outcomes. We conclude that many PNETs are highly vascular CNS tumors, indicating potent angiogenic activity. Therefore, these tumors would be good candidates for antiangiogenic strategies. However, MVD determined in the most active area of neovascularization is not a predictor of metastatic potential or survival outcomes in childhood PNET.


Subject(s)
Brain Neoplasms/blood supply , Neovascularization, Pathologic/pathology , Neuroectodermal Tumors, Primitive/blood supply , Adolescent , Adult , Brain Neoplasms/mortality , Brain Neoplasms/pathology , Cell Division/physiology , Cerebellar Neoplasms/blood supply , Cerebellar Neoplasms/mortality , Cerebellar Neoplasms/pathology , Child , Child, Preschool , Female , Follow-Up Studies , Glial Fibrillary Acidic Protein/metabolism , Humans , Infant , Male , Medulloblastoma/blood supply , Medulloblastoma/mortality , Medulloblastoma/pathology , Microcirculation/pathology , Neovascularization, Pathologic/mortality , Neuroectodermal Tumors, Primitive/mortality , Neuroectodermal Tumors, Primitive/pathology , Survival Rate
17.
Am J Ophthalmol ; 131(4): 442-5, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11292406

ABSTRACT

PURPOSE: To examine the potential for visual acuity loss, and its relation to extent and location of optic pathway gliomas in a cohort of children with neurofibromatosis type 1 studied with magnetic resonance imaging. METHODS: We reviewed the neuro-ophthalmologic records and brain/orbital magnetic resonance imaging scans for 43 consecutive pediatric patients with neurofibromatosis type 1 and optic pathway gliomas who were followed at the Children's Hospital of Philadelphia. The presence of visual loss, defined as abnormal visual acuity for age in one or both eyes, was determined. Optic pathway gliomas were classified by tumor extent and location according to involvement of the optic nerves, chiasm, and postchiasmal structures by magnetic resonance imaging. RESULTS: Involvement of the optic tracts and other postchiasmal structures at tumor diagnosis was associated with a significantly higher probability of visual acuity loss (P =.048, chi-square test). Visual loss was noted in 20 of 43 patients (47%) at a median age of 4 years; however, three patients developed visual acuity loss for the first time during adolescence. CONCLUSIONS: In pediatric patients with neurofibromatosis type 1 and optic pathway gliomas, the likelihood of visual loss is dependent on the extent and location of the tumor by magnetic resonance imaging and is particularly associated with involvement of postchiasmal structures. Furthermore, older age during childhood (adolescence) does not preclude the occurrence of visual loss. Close follow-up beyond the early childhood years, particularly for those with postchiasmal tumor, is recommended.


Subject(s)
Magnetic Resonance Imaging , Neurofibromatosis 1/diagnosis , Optic Chiasm/pathology , Optic Nerve Glioma/diagnosis , Optic Nerve Neoplasms/diagnosis , Vision Disorders/diagnosis , Visual Acuity , Adolescent , Child , Child, Preschool , Cohort Studies , Humans
18.
Neuro Oncol ; 3(1): 11-21, 2001 01.
Article in English | MEDLINE | ID: mdl-11305412

ABSTRACT

DNA damage produces delayed mitosis (G2/M delay) in proliferating cells, and shortening the delay sensitizes human malignant glioma and medulloblastoma cells to cytotoxic chemotherapy. Although activation of the cyclin-dependent kinase CDC2 mediates G2/M transition in all tumor cells studied to date, regulation of CDC2 varies between tumor types. Persistent hyperphosphorylation of kinase and reduced cyclin expression have been implicated as mediators of treatment-induced G2 delay in different tumor models. To evaluate regulation of G2/M transition in human brain tumors, we studied the expression and/or activity of CDC2 kinase and cyclins A and B1 in U-251 MG and DAOY medulloblastoma cells after their treatment with camptothecin (CPT). Synchronized cells were treated during S phase, then harvested at predetermined intervals for evaluation of cell cycle kinetics, kinase activity mRNA, and protein expression. CPT produced G2 delay associated with decreased CDC2 kinase activity and cyclin B1 expression. Kinase activity was associated with CDC2 bound to cyclin B1, not cyclin A, in both cell lines. Cyclin A mRNA and protein expression were reduced after CPT treatment; however, decreased protein expression was short lived and moderate in the glioma and primitive neuroectodermal tumor/medulloblastoma cells, respectively. We conclude that G2 delay is a common response of brain tumor cells to chemotherapy with topoisomerase I inhibitors and that a mechanism of this delay may be reduced expression of cyclin B1.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Brain Neoplasms/genetics , Camptothecin/pharmacology , Cyclin B/biosynthesis , Enzyme Inhibitors/pharmacology , G2 Phase/drug effects , Gene Expression Regulation, Neoplastic/drug effects , Glioma/genetics , Medulloblastoma/genetics , Neoplasm Proteins/biosynthesis , Topoisomerase I Inhibitors , Brain Neoplasms/pathology , CDC2 Protein Kinase/metabolism , Cyclin A/biosynthesis , Cyclin A/genetics , Cyclin B/genetics , Cyclin B1 , Glioma/pathology , Humans , Medulloblastoma/pathology , Neoplasm Proteins/antagonists & inhibitors , Neoplasm Proteins/genetics , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Tumor Cells, Cultured/drug effects
19.
Cancer Res ; 61(4): 1527-32, 2001 Feb 15.
Article in English | MEDLINE | ID: mdl-11245461

ABSTRACT

We examined the cytotoxicity of the immunosuppressant agent rapamycin and its analogue CCI-779 in human brain tumor cell lines in vitro and in vivo as single agents and in combination with standard chemotherapeutic drugs. In the rapamycin-sensitive PNET/MB cell line DAOY, rapamycin exhibited additive cytotoxicity with cisplatin and with camptothecin. In vivo, CCI-779 delayed DAOY xenograft growth by 160% after 1 week and 240% after 2 weeks of systemic treatment, compared with controls. Single high-dose treatment induced 37% regression of tumor solume. Growth inhibition of DAOY xenografts was 1.3 times greater after simultaneous treatment with CCI-779 and cisplatin than after cisplatin alone. Interestingly, CCI-779 also produced growth inhibition of xenografts derived from U251 malignant glioma cells, a human cell line resistant to rapamycin in vitro. These studies suggest that the rapamycin analogue CCI-779 is an important new agent to investigate in the treatment of human brain tumors, particularly PNET/MB.


Subject(s)
Antibiotics, Antineoplastic/pharmacology , Antineoplastic Combined Chemotherapy Protocols/pharmacology , Brain Neoplasms/drug therapy , Medulloblastoma/drug therapy , Neuroectodermal Tumors, Primitive/drug therapy , Sirolimus/analogs & derivatives , Sirolimus/pharmacology , Animals , Antibiotics, Antineoplastic/administration & dosage , Camptothecin/administration & dosage , Cell Division/drug effects , Cisplatin/administration & dosage , Drug Synergism , Female , Glioma/drug therapy , Growth Inhibitors/pharmacology , Humans , Mice , Mice, Nude , Sirolimus/administration & dosage , Tumor Cells, Cultured , Xenograft Model Antitumor Assays
20.
J Pediatr Hematol Oncol ; 23(1): 25-9, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11196266

ABSTRACT

PURPOSE: To assess if the abundance of apoptotic tumor cells is an independent prognostic factor in primitive neuroectodermal tumors (PNET) of the central nervous system. PATIENTS AND METHODS: Formalin-fixed paraffin-embedded tumor tissue sections from 78 clinically well-characterized children with PNET were evaluated by terminal deoxytransferase-mediated deoxyuridinie-5'-triphosphate (dUTP) nick-end labeling (TUNEL). Apoptotic indices (AI) were determined by counting TUNEL-positive tumor cells either in the highest staining region (AI hot spot) or in at least 15 randomly chosen fields (AI random). The AI hot spot and AI random were then correlated with clinical variables and survival outcome. RESULTS: AI hot spot (median 0.56%; range 0%-6.54%) and AI random (median 0.30%; range 0%-3.21%) showed considerable intertumor variability. Moreover, 53% of the evaluated PNET showed a more than two-fold difference between AI hot spot and AI random, showing important intratumoral variability of the abundance of apoptotic cells in a subset of the evaluated PNET. No significant associations were found between AI hot spot and AI random with clinical variables or survival outcome. CONCLUSION: The apoptotic index does not predict survival outcome and is not specifically associated with clinical variables of prognostic significance in childhood PNET.


Subject(s)
Apoptosis , Brain Neoplasms/pathology , Neuroectodermal Tumors, Primitive/pathology , Biopsy , Brain Neoplasms/mortality , Brain Neoplasms/therapy , Cerebellar Neoplasms/mortality , Cerebellar Neoplasms/pathology , Cerebellar Neoplasms/therapy , Child , Child, Preschool , Disease-Free Survival , Female , Humans , In Situ Nick-End Labeling/methods , Male , Meningeal Neoplasms/pathology , Meningeal Neoplasms/secondary , Neoplasm Staging , Neuroectodermal Tumors, Primitive/mortality , Neuroectodermal Tumors, Primitive/secondary , Neuroectodermal Tumors, Primitive/therapy , Prognosis , Retrospective Studies , Supratentorial Neoplasms/mortality , Supratentorial Neoplasms/pathology , Supratentorial Neoplasms/therapy , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL
...